港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

药明合联

56.550

-1.350-2.33%

成交量：769.82万

成交额：4.38亿

市值：681.43亿

市盈率：58.13

高：58.700

开：58.250

低：55.650

收：57.900

52周最高：64.450

52周最低：18.520

股本：12.05亿

香港流通股本：12.05亿

量比：0.91

换手率：0.64%

股息：- -

股息率：- -

每股收益(LYR):0.973

净资产收益率：19.76%

总资产收益率：9.04%

市净率：8.40

市盈率(LYR):58.13

市销率: 12.29

数据加载中...

总览公司新闻公告

药明合联(02268)出现大手买入9.25万股，成交价$57.2，涉资529.1万

阿斯达克财经

药明合联(02268)授出11.05万股受限制股份

里昂：升药明合联(02268.HK)目标价至70.7港元重申“跑赢大市”评级

大行评级｜里昂：对药明合联持有长期正面看法目标价上调至70.7港元

《大行》里昂一举升药明合联(02268.HK)目标价至70.7元重申“跑赢大市”评级

阿斯达克财经

港股生物医药股普遍上涨其中复宏汉霖涨5%金斯瑞生物医药涨3.6%药明合联涨超3%康方生物、荣昌生物、君实生物、百济神州均

ADC药物市场有多火爆？行业“卖水人”药明合联上调全年营收预期增速至45%以上

每日经济新闻

【券商聚焦】浦银国际维持药明合联(02268)“买入”评级指公司1H25业绩显著超市场预期

研报掘金｜中金：上调药明合联目标价至75港元中期业绩胜预期且订单增长强劲

建银国际：药明合联(02268.HK)中期业绩符预期升目标价至72港元

【特约大V】邓声兴：港股缺乏方向，25000区间上落

研报掘金｜华泰证券：上调药明合联目标价至82.24港元看好公司业绩增长潜力

大行评级｜花旗：药明合联上调2025财年收入增长指引目标价上调至70港元

大行评级｜建银国际：药明合联上半年业绩符合预期目标价上调至72港元

中金：维持药明合联(02268)跑赢行业评级升目标价至75港元

药明合联(02268)上调业绩指引龙头底气何在？

智通财经网

《大行》野村升药明合联(02268.HK)目标价至73.7元上半年业绩胜预期

阿斯达克财经

异动解读 | 药明合联中期业绩超预期盘中却意外大跌5.12%

异动解读 | 药明合联中期业绩优于预期股价却盘中大跌5.12%

药明合联CEO称来自美国的收入在加速增长

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02268/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02268","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":56.55,"timestamp":1756194221855,"preClose":57.9,"halted":0,"volume":7698210,"delay":0,"floatShares":1205000000,"shares":1205000000,"eps":0.9727368824291623,"marketStatus":"交易中","change":-1.35,"latestTime":"08-26 15:43:45","open":58.25,"high":58.7,"low":55.65,"amount":437608796,"amplitude":0.052677,"askPrice":56.6,"askSize":27000,"bidPrice":56.55,"bidSize":11000,"shortable":3,"etf":0,"ttmEps":1.1123258261181794,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":2,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":57.9,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.906126,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","floatShares":1205000000,"roa":"9.04%","roe":"19.76%","lyrEps":0.972737,"volumeRatio":0.906126,"shares":1205000000,"dividePrice":0,"high":58.7,"amplitude":0.052677,"preClose":57.9,"low":55.65,"week52Low":18.52,"pbRate":"8.40","psRate":"12.29","week52High":64.45,"institutionHeld":0,"latestPrice":56.55,"committee":-0.421053,"eps":0.9727368824291623,"divideRate":0,"volume":7698210,"delay":0,"ttmEps":1.1123258261181794,"open":58.25,"prevYearClose":30.65,"prevWeekClose":57.7,"prevMonthClose":57.7,"prevQuarterClose":41.6,"fiveDayClose":58.1,"twentyDayClose":61.75,"sixtyDayClose":39.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02268\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-20","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724117400000,"name":null,"time":"","dateTimestamp":1724083200000,"actualEps":null},{"date":"2024-03-25","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02268\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02268\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.5556,"hold":0.0556,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":18,"updateTime":1755878400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02268\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02268","date":"2025-08-25","current":48.107341,"percent":0.433645,"low":0.407466,"twenty":34.875245,"median":54.952855,"eighty":72.98104,"high":153.052589,"avg":54.216253,"sd":36.960472,"marketCap":69741982098},"quantilePoints":[{"date":"2020-08-28","current":0.43308,"twenty":0.448387,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-09-04","current":0.431618,"twenty":0.447817,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-11","current":0.431156,"twenty":0.447535,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-18","current":0.427016,"twenty":0.447373,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-25","current":0.430436,"twenty":0.447153,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-30","current":0.428392,"twenty":0.446995,"median":7.824737,"eighty":11.013173,"marketCap":323186685},{"date":"2020-10-09","current":0.422312,"twenty":0.446839,"median":7.815551,"eighty":11.015587,"marketCap":323186685},{"date":"2020-10-16","current":0.422486,"twenty":0.446689,"median":7.778238,"eighty":11.015587,"marketCap":323186685},{"date":"2020-10-23","current":0.421832,"twenty":0.446509,"median":7.763554,"eighty":11.013173,"marketCap":323186685},{"date":"2020-10-30","current":0.421767,"twenty":0.446296,"median":7.728277,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-06","current":0.416892,"twenty":0.446096,"median":7.681665,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-13","current":0.416542,"twenty":0.445828,"median":7.62168,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-20","current":0.413946,"twenty":0.445667,"median":7.588964,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-27","current":0.414916,"twenty":0.445574,"median":7.400318,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-04","current":0.411952,"twenty":0.44527,"median":7.31626,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-11","current":0.41294,"twenty":0.44498,"median":7.224146,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-18","current":0.412272,"twenty":0.444321,"median":7.177259,"eighty":11.047512,"marketCap":323186685},{"date":"2020-12-24","current":0.411847,"twenty":0.443892,"median":6.957959,"eighty":11.047512,"marketCap":323186685},{"date":"2020-12-31","current":0.411678,"twenty":0.44363,"median":6.764797,"eighty":11.047512,"marketCap":323186685},{"date":"2021-01-08","current":0.408416,"twenty":0.443491,"median":6.650061,"eighty":11.067383,"marketCap":323186685},{"date":"2021-01-15","current":0.408583,"twenty":0.442598,"median":6.55329,"eighty":11.072351,"marketCap":323186685},{"date":"2021-01-22","current":0.408755,"twenty":0.442234,"median":6.512372,"eighty":11.072351,"marketCap":323186685},{"date":"2023-11-17","current":130.035431,"twenty":0.435785,"median":0.444801,"eighty":2.787891,"marketCap":32996488000},{"date":"2023-11-24","current":133.579843,"twenty":0.435785,"median":0.444801,"eighty":2.810425,"marketCap":34174934000},{"date":"2023-12-01","current":147.707211,"twenty":0.435785,"median":0.444801,"eighty":2.852893,"marketCap":37945961200},{"date":"2023-12-08","current":132.646927,"twenty":0.435785,"median":0.444801,"eighty":2.935117,"marketCap":33939244800},{"date":"2023-12-15","current":138.75437,"twenty":0.435785,"median":0.444801,"eighty":3.039251,"marketCap":35706913800},{"date":"2023-12-22","current":153.052589,"twenty":0.435785,"median":0.444801,"eighty":3.172504,"marketCap":39360096400},{"date":"2023-12-29","current":145.85951,"twenty":0.435785,"median":0.444801,"eighty":3.326638,"marketCap":37710272000},{"date":"2024-01-05","current":142.305018,"twenty":0.435785,"median":0.444801,"eighty":3.599996,"marketCap":36531826000},{"date":"2024-01-12","current":138.558869,"twenty":0.435785,"median":0.444801,"eighty":3.622774,"marketCap":35589069200},{"date":"2024-01-19","current":141.046625,"twenty":0.435785,"median":0.444801,"eighty":3.635946,"marketCap":36178292200},{"date":"2024-01-26","current":116.23004,"twenty":0.435785,"median":0.444801,"eighty":3.642902,"marketCap":29696839200},{"date":"2024-02-02","current":82.111439,"twenty":0.435785,"median":0.444801,"eighty":3.654128,"marketCap":20952769880},{"date":"2024-02-09","current":67.278987,"twenty":0.435825,"median":0.445043,"eighty":3.68657,"marketCap":17252449440},{"date":"2024-02-16","current":66.713097,"twenty":0.435798,"median":0.44487,"eighty":3.704054,"marketCap":17111035920},{"date":"2024-02-23","current":82.124312,"twenty":0.435798,"median":0.44487,"eighty":3.728385,"marketCap":20952769880},{"date":"2024-03-01","current":86.135235,"twenty":0.435812,"median":0.444939,"eighty":3.767614,"marketCap":21989802360},{"date":"2024-03-08","current":96.662972,"twenty":0.435812,"median":0.444939,"eighty":3.804363,"marketCap":24688443700},{"date":"2024-03-15","current":72.134287,"twenty":0.435812,"median":0.444939,"eighty":3.87411,"marketCap":18407326520},{"date":"2024-03-22","current":82.739174,"twenty":0.435812,"median":0.444939,"eighty":3.907844,"marketCap":21094183400},{"date":"2024-03-28","current":70.236298,"twenty":0.435812,"median":0.444939,"eighty":3.924107,"marketCap":21565561800},{"date":"2024-04-05","current":69.514463,"twenty":0.435772,"median":0.444721,"eighty":3.932321,"marketCap":21329872600},{"date":"2024-04-12","current":72.929575,"twenty":0.435785,"median":0.444801,"eighty":3.970214,"marketCap":22390474000},{"date":"2024-04-19","current":66.691535,"twenty":0.435785,"median":0.444801,"eighty":4.01279,"marketCap":20457822560},{"date":"2024-04-26","current":78.851628,"twenty":0.435812,"median":0.444939,"eighty":62.837086,"marketCap":24158143000},{"date":"2024-05-03","current":79.483533,"twenty":0.435812,"median":0.444939,"eighty":66.70016,"marketCap":24334909900},{"date":"2024-05-10","current":73.189732,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":22461180760},{"date":"2024-05-17","current":65.221538,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19986444160},{"date":"2024-05-24","current":58.278715,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17818103520},{"date":"2024-05-31","current":59.948577,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":18347300940},{"date":"2024-06-07","current":58.299117,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17820354960},{"date":"2024-06-14","current":64.156468,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19592809620},{"date":"2024-06-21","current":70.500097,"twenty":0.435812,"median":0.444939,"eighty":69.593748,"marketCap":21485024730},{"date":"2024-06-28","current":68.013259,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":20718557850},{"date":"2024-07-05","current":61.893714,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":18850294830},{"date":"2024-07-12","current":63.530585,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":19377240810},{"date":"2024-07-19","current":56.933019,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17365265250},{"date":"2024-07-26","current":56.800526,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17389217340},{"date":"2024-08-02","current":69.358964,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":21221551740},{"date":"2024-08-09","current":72.710245,"twenty":0.435812,"median":0.444939,"eighty":70.597189,"marketCap":22395204150},{"date":"2024-08-16","current":74.003491,"twenty":0.435812,"median":0.444939,"eighty":70.930659,"marketCap":22802389680},{"date":"2024-08-23","current":35.050376,"twenty":0.435812,"median":0.44524,"eighty":71.736965,"marketCap":22742129354},{"date":"2024-08-30","current":36.779427,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":24024219892},{"date":"2024-09-06","current":36.193339,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":23652773101},{"date":"2024-09-13","current":36.950123,"twenty":0.435812,"median":0.445611,"eighty":71.736965,"marketCap":24084130665},{"date":"2024-09-20","current":36.912594,"twenty":0.435798,"median":0.445732,"eighty":71.812082,"marketCap":24203952211},{"date":"2024-09-27","current":41.596291,"twenty":0.435798,"median":0.446064,"eighty":71.812082,"marketCap":27439133942},{"date":"2024-10-04","current":49.267448,"twenty":0.435798,"median":0.446181,"eighty":71.812082,"marketCap":32351817312},{"date":"2024-10-10","current":43.61955,"twenty":0.435812,"median":0.446472,"eighty":71.736965,"marketCap":28457617080},{"date":"2024-10-18","current":43.201999,"twenty":0.435798,"median":0.446694,"eighty":71.812082,"marketCap":28038241670},{"date":"2024-10-25","current":43.020102,"twenty":0.435798,"median":0.446852,"eighty":71.812082,"marketCap":27918420124},{"date":"2024-11-01","current":41.699543,"twenty":0.435798,"median":0.446999,"eighty":71.812082,"marketCap":27079669305},{"date":"2024-11-08","current":47.130705,"twenty":0.435852,"median":0.447279,"eighty":71.812082,"marketCap":30374761809},{"date":"2024-11-15","current":46.740281,"twenty":0.435852,"median":0.44753,"eighty":71.812082,"marketCap":29895475627},{"date":"2024-11-22","current":46.01742,"twenty":0.435852,"median":0.447785,"eighty":71.812082,"marketCap":29416189444},{"date":"2024-11-29","current":51.670123,"twenty":0.435852,"median":0.448371,"eighty":71.812082,"marketCap":33010835812},{"date":"2024-12-06","current":54.048034,"twenty":0.435852,"median":0.449445,"eighty":71.812082,"marketCap":34448694360},{"date":"2024-12-13","current":58.707371,"twenty":0.435852,"median":0.45138,"eighty":71.812082,"marketCap":37384322227},{"date":"2024-12-20","current":60.54506,"twenty":0.435852,"median":35.016583,"eighty":71.812082,"marketCap":38342894592},{"date":"2024-12-27","current":58.22519,"twenty":0.435852,"median":35.863906,"eighty":71.812082,"marketCap":36845125272},{"date":"2025-01-03","current":57.033249,"twenty":0.435852,"median":36.241161,"eighty":71.812082,"marketCap":36126195998},{"date":"2025-01-10","current":62.66188,"twenty":0.435852,"median":36.730689,"eighty":71.812082,"marketCap":39541110048},{"date":"2025-01-17","current":54.642634,"twenty":0.436361,"median":37.212991,"eighty":71.812082,"marketCap":34508605132},{"date":"2025-01-24","current":54.868028,"twenty":0.436606,"median":39.470644,"eighty":71.812082,"marketCap":34868069769},{"date":"2025-01-28","current":52.331181,"twenty":0.436643,"median":41.238065,"eighty":71.736965,"marketCap":33430211222},{"date":"2025-02-07","current":57.910706,"twenty":0.437089,"median":42.380717,"eighty":71.8872,"marketCap":36785214499},{"date":"2025-02-14","current":56.82028,"twenty":0.437089,"median":43.020102,"eighty":71.8872,"marketCap":36006374452},{"date":"2025-02-21","current":70.802488,"twenty":0.437089,"median":44.139364,"eighty":71.8872,"marketCap":45112811918},{"date":"2025-02-28","current":60.65941,"twenty":0.437089,"median":45.078416,"eighty":71.8872,"marketCap":38522626910},{"date":"2025-03-07","current":67.088057,"twenty":0.437583,"median":46.607669,"eighty":71.962317,"marketCap":42776291779},{"date":"2025-03-14","current":72.98104,"twenty":0.438098,"median":47.703312,"eighty":71.990989,"marketCap":46550670465},{"date":"2025-03-21","current":80.244903,"twenty":0.438098,"median":49.592986,"eighty":72.978175,"marketCap":51163799971},{"date":"2025-03-28","current":47.906694,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":54840613248},{"date":"2025-04-03","current":43.121995,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":49380552191},{"date":"2025-04-11","current":35.581021,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":40380451549},{"date":"2025-04-17","current":33.597127,"twenty":0.4381,"median":49.700845,"eighty":72.980467,"marketCap":38220427395},{"date":"2025-04-25","current":39.226609,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44663120338},{"date":"2025-05-02","current":40.829264,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":46586700218},{"date":"2025-05-09","current":38.818219,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44603008467},{"date":"2025-05-16","current":39.608151,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":45882474676},{"date":"2025-05-23","current":38.196121,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44379117053},{"date":"2025-05-30","current":41.172242,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48047309655},{"date":"2025-06-06","current":42.866418,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":50152010328},{"date":"2025-06-13","current":46.041552,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":53888090995},{"date":"2025-06-20","current":41.240748,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48174509918},{"date":"2025-06-27","current":40.971553,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":47994081042},{"date":"2025-07-04","current":46.000985,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":53888090995},{"date":"2025-07-11","current":47.288014,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":55339986740},{"date":"2025-07-18","current":50.925924,"twenty":0.438098,"median":50.569275,"eighty":72.98104,"marketCap":59550637905},{"date":"2025-07-25","current":57.660678,"twenty":0.438098,"median":51.683826,"eighty":72.98104,"marketCap":67671179437},{"date":"2025-08-01","current":57.245588,"twenty":0.438098,"median":52.545804,"eighty":72.98104,"marketCap":66768897045},{"date":"2025-08-08","current":57.73965,"twenty":0.43811,"median":53.257543,"eighty":72.98104,"marketCap":67513611340},{"date":"2025-08-15","current":64.222783,"twenty":31.309336,"median":54.856958,"eighty":72.98104,"marketCap":74981664691},{"date":"2025-08-22","current":48.130228,"twenty":34.419063,"median":54.952855,"eighty":72.98104,"marketCap":69501077151},{"date":"2025-08-25","current":48.107341,"twenty":34.875245,"median":54.952855,"eighty":72.98104,"marketCap":69741982098}],"updateTime":1756189145828},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02268\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562218403","title":"药明合联(02268)出现大手买入9.25万股，成交价$57.2，涉资529.1万","url":"https://stock-news.laohu8.com/highlight/detail?id=2562218403","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562218403?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 13:49","pubTimestamp":1756100940,"startTime":"0","endTime":"0","summary":"[大手成交]药明合联(02268)在下午01:49出现大手买入，成交量为9.25万，成交价为港币$57.2，涉资529.1万。至目前为止，股价跌1.127%，今日最高价为$59.15，而最低价为$56.6，总成交量为461.592万股，总成交金额港币$2.664亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2508259089/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["SG9999014674.SGD","LU2488822045.USD","02268","BK1141"],"gpt_icon":0},{"id":"2561319408","title":"药明合联(02268)授出11.05万股受限制股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2561319408","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561319408?lang=zh_cn&edition=fundamental","pubTime":"2025-08-22 22:16","pubTimestamp":1755872202,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明合联(02268)发布公告，于2025年8月22日，根据2024年股份计划，其已批准向7名承授人(为集团雇员)授出11.05万股受限制股份，惟须经选定参与者接纳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1333955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2561459024","title":"里昂：升药明合联(02268.HK)目标价至70.7港元 重申“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2561459024","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561459024?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 14:51","pubTimestamp":1755759085,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SG9999014674.SGD","LU2488822045.USD","02268","BK1141"],"gpt_icon":0},{"id":"2561143744","title":"大行评级｜里昂：对药明合联持有长期正面看法 目标价上调至70.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561143744","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561143744?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 11:59","pubTimestamp":1755748748,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4080","BK1141","LU2488822045.USD","02268","SG9999014674.SGD","ADC","BK4231"],"gpt_icon":0},{"id":"2561348494","title":"《大行》里昂一举升药明合联(02268.HK)目标价至70.7元  重申“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2561348494","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561348494?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 10:09","pubTimestamp":1755742140,"startTime":"0","endTime":"0","summary":"里昂发表研究报告指，药明合联上半年收入及经调整净利润分别按年增长62%及50%，符合此前盈利预告。管理层将2025年收入增长指引从35%上调至45%，主要来自强劲的ADC外包需求及稳健在手订单。里昂对药明合联持有长期正面看法，重申“跑赢大市”评级，目标价从47.3元上调至70.7元，将2025至2027年收入及净利润预测上调7%至8%及13%至17%，目前预测2025至2027年收入将分别增长45%、31%及27%。沽空资料截至 2025-08-20 16:25。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1462915/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"gpt_icon":0},{"id":"2561439011","title":"港股生物医药股普遍上涨其中复宏汉霖涨5%金斯瑞生物医药涨3.6%药明合联涨超3%康方生物、荣昌生物、君实生物、百济神州均","url":"https://stock-news.laohu8.com/highlight/detail?id=2561439011","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561439011?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 09:57","pubTimestamp":1755741426,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","IE00B543WZ88.USD","BK1141","IE00BPRC5H50.USD","LU1794554557.SGD","LU1969619763.USD","HSCEI","BK4139","HSTECH","LU0348783233.USD","LU1064130708.USD","161726","LU1064131003.USD","LU2148510915.USD","LU0588546209.SGD","BK1574","LU1720050803.USD","LU2328871848.SGD","BK1161","LU2488822045.USD","688331","BK1583","159938","LU0307460666.USD","09995","BK1515","02268","02696","BK0239","BK4614","BK4526","ONC","01877","06160","07226","688180","BK1500","IE00B5MMRT66.SGD","LU0417516571.SGD","SG9999014674.SGD","09939","BK1588","399441","688235","LU0348784397.USD","09926","YANG"],"gpt_icon":0},{"id":"2560107296","title":"ADC药物市场有多火爆？行业“卖水人”药明合联上调全年营收预期增速至45%以上","url":"https://stock-news.laohu8.com/highlight/detail?id=2560107296","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560107296?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 23:18","pubTimestamp":1755703108,"startTime":"0","endTime":"0","summary":"记者从药明合联（02268.HK，股价57.65港元，市值694亿港元）近日举行的业绩电话会上获悉，基于在手订单与产能释放节奏，公司将2025年全年营业收入同比增长预期从35%上调至超过45%。公司方面表示，此次业绩指引上调，源于行业景气度延续、订单储备充足、项目进展加快、产能释放加速等多重利好因素叠加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202508203489783083.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202508203489783083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02268","ADC"],"gpt_icon":0},{"id":"2560173342","title":"【券商聚焦】浦银国际维持药明合联(02268)“买入”评级 指公司1H25业绩显著超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2560173342","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560173342?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 16:11","pubTimestamp":1755677462,"startTime":"0","endTime":"0","summary":"金吾财讯 | 浦银国际发研报指，药明合联 1H25业绩显著超市场预期，且略好于此前公布的盈利预告。公司表示，新签项目数好于预期的增长既受到美国市场快速发展的驱动，也受到整体偶联药物市场的高速发展的推动，以前尚未进入ADC/XDC药物的Pharma/Biotech公司今年开始进入到ADC赛道。在37个新签约的iCMC项目中，美国和中国增长势头最为强劲，其中50%+是处于早期阶段极具差异化的ADC靶点，且新型偶联药物与非肿瘤领域均呈现出快速同比增长。维持“买入”评级。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/ZmQ4YWNjMjZmNDUwZDg4ZTlkYjEwZTY1NmI3NmEzMzkwOTI4OTA5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZmQ4YWNjMjZmNDUwZDg4ZTlkYjEwZTY1NmI3NmEzMzkwOTI4OTA5.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1964457","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2560128083","title":"研报掘金｜中金：上调药明合联目标价至75港元 中期业绩胜预期且订单增长强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2560128083","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560128083?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 11:40","pubTimestamp":1755661213,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["ADC.AU","09939","BK1574","BK4080","BK4231","LU2488822045.USD","BK1515","159938","ADC","BK1141","SG9999014674.SGD","BK7095","BK1161","02268"],"gpt_icon":0},{"id":"2560128826","title":"建银国际：药明合联(02268.HK)中期业绩符预期 升目标价至72港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560128826","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560128826?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 11:05","pubTimestamp":1755659115,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CYB","MCNHmain","BK1141","CNHmain","02268","MUCmain","LU2488822045.USD","SG9999014674.SGD","UCmain"],"gpt_icon":0},{"id":"2560277140","title":"【特约大V】邓声兴：港股缺乏方向，25000区间上落","url":"https://stock-news.laohu8.com/highlight/detail?id=2560277140","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560277140?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 10:59","pubTimestamp":1755658797,"startTime":"0","endTime":"0","summary":"国指跌27点或0.3%，报9006；科指跌37点或0.67%，报5542。Palantir再泻9.4%，由纪录高位连续第5个交易日滑落。港股缺乏方向，25000区间上落。未完成订单总量13.29亿美元同比增长57.9%，展现强劲增长动能。生产能力持续强化，上半年完成4个PPQ阶段组分生产，为商业化量产奠定基础。集团市占率亦从2022年9.9%跃升至2025年上半年约22%，稳居ADC CRDMO领域领先地位。目标价$68，止蚀价$52。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1964419","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRHKY","LU0328353924.USD","BK1180","SG9999014674.SGD","02268","LU1794554557.SGD","BK1521","BK1583","LU2488822045.USD","LU0359201612.USD","BK1578","YANG","03990","IE00BPRC5H50.USD","IE00B0169L03.USD","BK1570","BK4614","BK1240","80291","LU1023057109.AUD","IE0008368742.USD","BK1510","LU1328615791.USD","HSTECH","BK1589","IE00B29SXG58.USD","IE0008369823.USD","IE00B5MMRT66.SGD","LU1769817179.HKD","00291","IE00B543WZ88.USD","SG9999006514.SGD","BK1141","IE00B031HY20.USD","LU1720050803.USD","BK1604","IE0031814852.USD","LU1769817096.USD","LU0359202008.SGD","HSCEI"],"gpt_icon":1},{"id":"2560406001","title":"研报掘金｜华泰证券：上调药明合联目标价至82.24港元 看好公司业绩增长潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2560406001","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560406001?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 10:52","pubTimestamp":1755658364,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SG9999013460.SGD","SG9999001846.SGD","SG9999014492.USD","LU2242646235.USD","LU2242652126.USD","BK6523","BK1141","S68.SI","ADC","SG9999003826.SGD","SG9999004360.SGD","LU0898667661.SGD","LU0326948709.USD","LU1920062954.HKD","SG9999013478.USD","LU2488822045.USD","SG9999014674.SGD","LU1920063259.USD","SG9999000343.SGD","SG9999014484.SGD","BK4080","LU2401740654.USD","SGXZ58947870.SGD","BK6033","BK6516","LU0877626530.USD","SG9999006266.SGD","02268","LU0831103253.SGD","LU0192582467.USD","LU1119993845.HKD","SG9999013486.USD","SGXZ27511609.SGD","BK1564","LU0188438112.USD","ES3.SI","STI.SI","FSTM.SI","SG9999001135.SGD","LU0205439572.USD","LU2242646821.SGD","BK4231","BK1147","SG9999016042.SGD","FSTAS.SI","HTSC.UK","06886"],"gpt_icon":0},{"id":"2560140832","title":"大行评级｜花旗：药明合联上调2025财年收入增长指引 目标价上调至70港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560140832","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560140832?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 10:42","pubTimestamp":1755657741,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0310800965.SGD","BK4207","BK4566","BK1141","LU2462157665.USD","LU0162691827.USD","02268","LU2417539215.USD","LU1267930227.SGD","LU0648001328.SGD","LU1162221912.USD","LU0072461881.USD","LU2125154778.USD","BK4588","BK4504","LU2360032135.SGD","BK4585","BK4534","LU2456880835.USD","LU0130517989.USD","LU1244550577.SGD","LU2125154935.USD","LU0128525689.USD","LU2236285917.USD","LU1366192091.USD","LU1244550494.USD","LU1668664300.SGD","LU1201861249.SGD","IE00BSNM7G36.USD","LU0106831901.USD","LU1791807156.HKD","BK4559","LU0320765646.SGD","LU0130102774.USD","LU0477156953.USD","LU2488822045.USD","LU0098860793.USD","LU1244550221.USD","LU0052756011.USD","LU0170899867.USD","LU0980610538.SGD","SG9999014674.SGD"],"gpt_icon":0},{"id":"2560147450","title":"大行评级｜建银国际：药明合联上半年业绩符合预期 目标价上调至72港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560147450","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560147450?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 10:28","pubTimestamp":1755656897,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2488822045.USD","SG9999014674.SGD","BK1141","02268"],"gpt_icon":0},{"id":"2560314713","title":"中金：维持药明合联(02268)跑赢行业评级 升目标价至75港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560314713","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560314713?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 10:17","pubTimestamp":1755656276,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，考虑到全球ADC研发及生产需求景气度高且药明合联领先地位持续巩固，上调2025/2026年经调整净利润预测6.3%/10.2%至16.9/23.3亿元，当前股价对应2025/2026年经调整P/E为40.3x/28.7x，考虑到近期医药板块估值中枢上移，该行上调目标价66.7%至75港币，对应2025/2026年经调整P/E为49.1x/35.0x，相比当前股价上行空间21.9%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1331928.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268"],"gpt_icon":0},{"id":"2560141888","title":"药明合联(02268)上调业绩指引 龙头底气何在？","url":"https://stock-news.laohu8.com/highlight/detail?id=2560141888","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560141888?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 08:42","pubTimestamp":1755650564,"startTime":"0","endTime":"0","summary":"药明合联(02268)在8月19日举行的业绩电话会上，进一步释放积极信号：基于在手订单与产能释放节奏，将2025年全年营业收入同比增长预期从35%上调至45%以上，凸显其对市场趋势的精准把握与长期发展信心。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20250820/20250820083617_27662.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250820/20250820083617_27662.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1331879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02268","BK1141","LU2488822045.USD","SG9999014674.SGD"],"gpt_icon":0},{"id":"2560156795","title":"《大行》野村升药明合联(02268.HK)目标价至73.7元  上半年业绩胜预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2560156795","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560156795?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 10:55","pubTimestamp":1755572100,"startTime":"0","endTime":"0","summary":"野村研究报告指，药明合联上半年收入及盈利分别按年升62%及53%，至27亿及7.46亿元人民币，均较该行预期高。强劲收入表现主要因全球抗体偶联药物研发强劲及公司竞争力，管理层透露市占率由2023年14.8%，升至去年至今年上半年22.2%。另外，截至上半年末，公司拥有225个综合项目，积压订单达13亿美元，较去年末增加34%。该行将2025及26年的收入预测分别上调9.8%及14%，盈利预测分别上调7.3%及15.1%。维持“买入”评级，目标价由56.55港元升至73.7港元。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1462121/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"gpt_icon":0},{"id":"1141797960","title":"异动解读 | 药明合联中期业绩超预期 盘中却意外大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141797960","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141797960?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 10:20","pubTimestamp":1755570053,"startTime":"0","endTime":"0","summary":"港股药明合联今日盘中出现意外大跌，截至上午10时18分，跌幅达5.12%，引发市场关注。这一跌势与该公司昨日发布的强劲中期业绩形成鲜明对比。根据药明合联8月18日发布的2025年中期业绩报告，公司上半年实现营收27.01亿元人民币，同比大幅增长62.2%；归属于公司股东的净利润为7.46亿元，同比增长52.74%；每股基本盈利0.62元，同比增长51.22%。然而，尽管业绩表现亮眼，药明合联的股价却出现大幅下跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02268"],"gpt_icon":0},{"id":"1106876773","title":"异动解读 | 药明合联中期业绩优于预期 股价却盘中大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1106876773","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106876773?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 10:20","pubTimestamp":1755570053,"startTime":"0","endTime":"0","summary":"药明合联今日盘中大跌5.12%，引发市场关注。尽管公司刚刚发布的中期业绩表现亮眼，但投资者似乎对其未来增长前景持谨慎态度。根据公司公告，药明合联2025年上半年实现收入27.01亿元人民币，同比大幅增长62.2%；公司拥有人应占纯利7.46亿元人民币，同比增长52.74%。此外，部分投资者可能选择在良好业绩公布后获利了结，导致股价承压。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02268"],"gpt_icon":0},{"id":"2560915835","title":"药明合联CEO称来自美国的收入在加速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2560915835","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560915835?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 09:23","pubTimestamp":1755566637,"startTime":"0","endTime":"0","summary":"8月19日，药明合联CEO李锦才在业绩沟通会上表示，公司来自美国的营收在加速增长。2025年上半年，该公司来自美国的收入占比突破52%。上半年，药明合联收入同比增长62.6%至27.01亿元人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/19092352520919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2488822045.USD","BK1141","SG9999014674.SGD","02268"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":183,"code":"91000000","status":"200"}]}}